Statistics for Oncocyterp (id:5921 OCX)

Valuation metrics

Market cap

46.30M

Enterprise value

35.60M

Trailing P/E (ttm)

-0.73

Forward P/E

-1.59

PEG ratio

-1.59

Price/Sales (ttm)

65.30

Price/Book (mrq)

3.88

Enterprise Value/Revenue

50.21

Enterprise Value/EBITDA

-1.65

Overview

Shares outstanding

16.84M

Float

5.57M

Shares short

194.19K

% Held by insiders

0.16%

% Held by institutions

0.51%

Average volume (10 days)

105.90K

Average volume (90 days)

Price summary

52-Week low

2.28

52-Week high

4.30

52-Week change

-44.36%

Beta

1.00

50-Day moving average

3.01

200-Day moving average

2.95

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

July 25th, 2023

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

27.48%

Operating margin

-5,543.48%

Operational effectiveness

Return on assets

-18.84%

Return on equity

-165.32%

Income statement

Revenue (ttm)

0.07

Revenue per share (ttm)

0.07

Quarterly revenue growth (yoy)

Gross profit (ttm)

413.00K

EBITDA

-21,556,000.00

Net income to common (ttm)

-43,347,000.00

Diluted EPS (ttm)

-4.44

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

3.36M

Total cash per share (mrq)

0.24

Total debt (mrq)

3.99M

Total Debt/Equity (mrq)

41.10

Current ratio (mrq)

52.70%

Book value per share (mrq)

0.71

Cash flow

Cash flow statement

-21,293,000.00

Levered free cash flow (LFCF)

-7,611,000.00